| Literature DB >> 18375968 |
Damir Erkapic1, Thomas Neumann, Jörn Schmitt, Johannes Sperzel, Alexander Berkowitsch, Malte Kuniss, Christian W Hamm, Heinz-Friedrich Pitschner.
Abstract
We described a case of a 58-year-old man with organic changes consistent with right ventricular cardiomyopathy. He also had a loss-of-function mutation in the cardiac sodium channel gene SCN5A, described in Brugada syndrome. He first presented with non-sustained ventricular tachycardia and was implanted with an implantable cardioverter defibrillator. He remained asymptomatic for 8 years until he developed recurrent episodes of ventricular tachyarrhythmias, which required multiple shocks. The patient was treated with a combination of quinidine and verapamil and since then remained free of arrhythmias.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18375968 DOI: 10.1093/europace/eun065
Source DB: PubMed Journal: Europace ISSN: 1099-5129 Impact factor: 5.214